Improving Treatment for Severe Dry Eye Disease
Part of Eyes & vision clinical trials.
This study helps doctors find better ways to treat severe dry eye disease. Researchers will perform eye exams and ask questions to understand your condition better and optimize your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 21 or older
- Previously diagnosed with dry eye disease by an eye doctor
- Have received some form of dry eye treatment before (such as artificial tears or prescription eye drops)
- Able and willing to complete eye exams and answer questionnaires
- Able to provide informed consent and understand the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether low-level light therapy can improve dry eye disease by measuring changes in tear proteins. It may help people with chronic dry eye who are interested in a non-drug treatment.
This research study aims to develop better ways to diagnose and manage dry eye disease in people who need cataract surgery. If you have dry eye or not, your participation will help create better care plans.
This study uses a special microscope to look at the surface of your eye to help doctors better diagnose dry eye disease. If you have dry eye symptoms or healthy eyes, you may be able to join.
This study tests whether eye drops made from your own blood serum (with a natural lubricant) can relieve moderate-to-severe dry eye better than a standard salt solution. If you have dry eye from certain immune conditions or nerve damage, this may help find a more effective treatment.
This study tests a new eye drop treatment made from your own blood serum for severe dry eye that hasn't improved with standard treatments. Researchers will analyze proteins in your tears to understand why this treatment works and who benefits most.
This study tests an investigational eye drop called OT202 to see if it helps people with moderate to severe dry eye. If you join, you'll receive either the study drug or a placebo (no active ingredient) and have your symptoms and eye health monitored for several months.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.